Molly Henderson, Chief Financial Officer at UroGen Pharma Ltd. (URGN), sold 331 shares at $7.58 ($3K) on 2022-01-31, disclosed to the SEC on 2022-02-02.
Open-market sale of $3k URGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |